Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104970455 | 10497045 | 5 | F | 20140313 | 20160721 | 20141006 | 20160722 | EXP | DE-ROCHE-1467706 | ROCHE | 66.00 | YR | F | Y | 83.00000 | KG | 20160722 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104970455 | 10497045 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 825 | MG | SOLUTION FOR INFUSION | QOW | ||||||
| 104970455 | 10497045 | 2 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 825 | MG | SOLUTION FOR INFUSION | QOW | ||||||
| 104970455 | 10497045 | 3 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1300 | MG | SOLUTION FOR INFUSION | Q3W | ||||||
| 104970455 | 10497045 | 4 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | U | 0 | 168 | MG | /wk | |||||||
| 104970455 | 10497045 | 5 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | U | 0 | 168 | MG | /wk | |||||||
| 104970455 | 10497045 | 6 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | U | 0 | 168 | MG | /wk | |||||||
| 104970455 | 10497045 | 7 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | U | 0 | 168 | MG | /wk | |||||||
| 104970455 | 10497045 | 8 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | U | 0 | 168 | MG | /wk | |||||||
| 104970455 | 10497045 | 9 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | U | 0 | 168 | MG | /wk | |||||||
| 104970455 | 10497045 | 10 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | U | 0 | 168 | MG | /wk | |||||||
| 104970455 | 10497045 | 11 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | U | 0 | 168 | MG | /wk | |||||||
| 104970455 | 10497045 | 12 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | U | 0 | 168 | MG | /wk | |||||||
| 104970455 | 10497045 | 13 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | U | 0 | 168 | MG | /wk | |||||||
| 104970455 | 10497045 | 14 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | U | 0 | 168 | MG | /wk | |||||||
| 104970455 | 10497045 | 15 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | U | 0 | 168 | MG | /wk | |||||||
| 104970455 | 10497045 | 16 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | U | 0 | 168 | MG | /wk | |||||||
| 104970455 | 10497045 | 17 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | U | 0 | 168 | MG | /wk | |||||||
| 104970455 | 10497045 | 18 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | U | 0 | 168 | MG | /wk | |||||||
| 104970455 | 10497045 | 19 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | U | 0 | 168 | MG | /wk | |||||||
| 104970455 | 10497045 | 20 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | U | 0 | 168 | MG | /wk | |||||||
| 104970455 | 10497045 | 21 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | U | 0 | 144 | MG | /wk | |||||||
| 104970455 | 10497045 | 22 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 0 | 95 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 104970455 | 10497045 | 1 | Breast cancer metastatic |
| 104970455 | 10497045 | 4 | Breast cancer metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 104970455 | 10497045 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 104970455 | 10497045 | Alopecia | |
| 104970455 | 10497045 | Aphasia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 104970455 | 10497045 | 1 | 20140102 | 20140102 | 0 | |
| 104970455 | 10497045 | 2 | 20140306 | 20140306 | 0 | |
| 104970455 | 10497045 | 3 | 20140813 | 0 | ||
| 104970455 | 10497045 | 4 | 20140102 | 0 | ||
| 104970455 | 10497045 | 5 | 20140109 | 0 | ||
| 104970455 | 10497045 | 6 | 20140116 | 0 | ||
| 104970455 | 10497045 | 7 | 20140206 | 0 | ||
| 104970455 | 10497045 | 8 | 20140213 | 0 | ||
| 104970455 | 10497045 | 9 | 20140220 | 0 | ||
| 104970455 | 10497045 | 10 | 20140306 | 0 | ||
| 104970455 | 10497045 | 11 | 20140313 | 0 | ||
| 104970455 | 10497045 | 12 | 20140320 | 0 | ||
| 104970455 | 10497045 | 13 | 20140403 | 0 | ||
| 104970455 | 10497045 | 14 | 20140410 | 0 | ||
| 104970455 | 10497045 | 15 | 20140417 | 0 | ||
| 104970455 | 10497045 | 16 | 20140502 | 0 | ||
| 104970455 | 10497045 | 17 | 20140509 | 0 | ||
| 104970455 | 10497045 | 18 | 20140516 | 0 | ||
| 104970455 | 10497045 | 19 | 20140530 | 0 | ||
| 104970455 | 10497045 | 20 | 20140611 | 0 | ||
| 104970455 | 10497045 | 21 | 20140618 | 20140618 | 0 | |
| 104970455 | 10497045 | 22 | 2007 | 0 |